ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BCTX BriaCell Therapeutics Corporation

2.28
0.01 (0.44%)
시간외 거래
최종 업데이트: 06:16:11
15분 지연
기업명 주식 심볼 시장 주식 타입
BriaCell Therapeutics Corporation BCTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01 0.44% 2.28 06:16:11
개장가 저가 고가 종가 전일 종가
2.24 2.19 2.28 2.19 2.27
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202421:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
10/04/202421:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
09/04/202421:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
07/03/202422:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
06/03/202422:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
27/02/202422:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
07/02/202422:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
06/02/202422:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
01/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
01/02/202407:24EDGAR2Form 8-K - Current report
31/01/202412:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
23/01/202407:00EDGAR2Form S-3 - Registration statement under Securities Act of..
10/01/202406:05EDGAR2Form DEF 14A - Other definitive proxy statements
04/01/202422:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
28/12/202322:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
21/12/202306:05EDGAR2Form 8-K - Current report
20/12/202322:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
15/12/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/12/202307:00EDGAR2Form 8-K - Current report
06/12/202323:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
06/12/202323:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
30/11/202321:00EDGAR2Form 8-K - Current report
30/11/202321:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
03/11/202321:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
25/10/202322:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
20/10/202322:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
18/10/202322:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
11/10/202322:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
04/10/202322:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
03/10/202322:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
08/09/202320:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
01/09/202300:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
31/08/202321:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
26/08/202303:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
19/08/202301:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
16/08/202321:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
27/06/202322:37APSNews Brief: BriaCell Therapeutics Corp.
27/06/202321:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..
25/05/202322:00GLOBEBriaCell Enters Definitive Arrangement Agreement for the..
20/05/202300:38GLOBEBriaCell Closes $4 Million Strategic Investment by Prevail..
15/05/202321:00GLOBEBriaCell Announces $4 Million Strategic Investment and..

최근 히스토리

Delayed Upgrade Clock